BiomarkersReview

The emerging landscape of circulatory biomarkers in Alzheimer's disease

Figure 1 from International Review of Neurobiology — Figure 1Kumari et al.

International Review of Neurobiology

The paper

Sakshi Kumari, Amaan Rais, Mohd Suhail Ashar,

Abhinay Kumar Singh, Masroor Anwar, Rashmita Pradhan,

All India Institute of Medical Sciences

International Review of Neurobiology · 24 Aug 2026

doi.org/10.1016/bs.irn.2026.08.008 PubMed 42785898

Reduced peptide amidation links to higher Alzheimer's risk
Alzheimer's Research & Therapy · 4 Oct 2026
Plasma pTau217 and recall test refine prognosis in Down syndrome
Annals of Neurology · 4 Oct 2026
High neutrophil-to-lymphocyte ratio predicts cognitive decline
Frontiers in Aging Neuroscience · 4 Oct 2026
Plasma p-tau217 yields discordant Alzheimer results in 8.5% of adults
Neurology · 4 Oct 2026